Service Catalog
Liraglutide Identity Confirmation
Confirms molecular identity of liraglutide via LC-MS/MS analysis.
Liraglutide Impurity Profiling
Profiles secondary peaks and potential impurities with LC-MS.
Liraglutide Purity Testing
Determines peptide purity level through HPLC chromatographic separation.
Liraglutide Quantitative Assay
Quantifies liraglutide concentration against a certified reference standard.
Liraglutide Sterility + Endotoxin
Sterility testing per USP <71> and endotoxin detection via LAL method.
Semaglutide Identity Confirmation
Confirms molecular identity of semaglutide via LC-MS/MS analysis.
Semaglutide Purity Testing
Determines peptide purity level through HPLC chromatographic separation.
Semaglutide Impurity Profiling
Advanced impurity mapping tailored for structurally complex peptides.
Semaglutide Quantitative Assay
Quantifies semaglutide concentration with enhanced calibration accuracy.
Semaglutide Sterility + Endotoxin
Sterility testing and endotoxin screening specific to multi-target peptide classes.
Tirzepatide Identity Confirmation
Confirms the molecular identity of tirzepatide using LC-MS/MS and HPLC. High-resolution mass analysis ensures accurate sequence confirmation of this complex dual agonist peptide.
Tirzepatide Purity Testing
Quantifies percentage purity through advanced HPLC profiling. Optimized for long-chain GLP-1/GIP analogs like tirzepatide.
Tirzepatide Impurity Profiling
Detects process-related impurities, degradation products, and sequence truncations using HPLC and high-resolution MS.
Tirzepatide Quantitative Assay
Assesses tirzepatide content using validated UV-Vis and HPLC calibration curves against pharmacopeial-grade standards.
Tirzepatide Sterility + Endotoxin
Includes USP <71> sterility testing and quantitative endotoxin detection via kinetic turbidimetric LAL method—ideal for injectable-grade analysis.
Retatrutide Identity Confirmation
High-resolution LC-MS/MS analysis to confirm the identity of retatrutide, including molecular weight, structure-specific fragments, and purity traceability.
Retatrutide Purity Testing
Uses extended-time HPLC runs with enhanced separation parameters for accurate quantification of this triagonist’s peptide content.
Retatrutide Impurity Profiling
Advanced detection of synthesis-related impurities, fragmentations, and degradation products using combined HPLC and HR-MS mapping.
Retatrutide Quantitative Assay
Evaluates retatrutide concentration against multi-standard calibration curves for ultra-precise assay results.
Retatrutide Sterility + Endotoxin
Sterility confirmation per USP <71> and endotoxin screening via gel-clot and kinetic turbidimetric LAL methods—tailored for complex triagonist formulations.
Amino Acid Analysis (AAA)
Determines the actual sequence and composition of peptides.
Residual Solvent Analysis (GC-MS)
Detects solvents like ethanol, acetonitrile, DMSO — common in synthesis or dilution.
Heavy Metals Screening (ICP-MS)
Screens for arsenic, lead, mercury, cadmium — critical for injectables and clinical-grade products.
pH and Osmolality Testing
Ensures injectable formulations fall within safe physiologic range.
Microbial Contamination Testing
Tests total aerobic microbial count & yeast/mold count.
pH Stability Curve (Accelerated Stability)
Simulates storage/transport degradation at various pH and temperature conditions.
Visual Inspection (Particulate Matter)
Manual and microscopic inspection for visible contaminants (fibers, floaters, etc.).
Osmolality Testing
Confirms injectable solutions are iso-osmotic or physiologically acceptable.
Endotoxin Quantification (Kinetic Chromogenic LAL)
A more specific, quantifiable version of the standard LAL test.
Stability Under Light & Heat (ICH Guidelines)
Mimics real-world shipping/handling degradation.
Peptide Aggregation Assay
Confirms whether peptides are forming unwanted aggregates (clumps) in solution — a big concern in injectable peptide stability and bioavailability.
Visual Identification
Checks if a compound absorbs at its expected wavelength.